Concept information
Preferred term
Pravastatin
Type
-
mesh:Descriptor
Definition
- An antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES).
Broader concept
Entry terms
- 124917-23-3 (cpd without configurational designation, mono-Na salt)
- 3M8608UQ61
- 81093-37-0 (Pravastatin)
- 81131-70-6 (Na salt)
- 81131-74-0 ((6 beta)-isomer)
- 81176-41-2 ((6 beta)-isomer, mono-Na salt)
- Eptastatin
- KXO2KT9N0G
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- biosynthesis (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- genetics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
124917-23-3 (cpd without configurational designation, mono-Na salt)
-
3M8608UQ61
-
81093-37-0 (Pravastatin)
-
81131-70-6 (Na salt)
-
81131-74-0 ((6 beta)-isomer)
-
81176-41-2 ((6 beta)-isomer, mono-Na salt)
-
Eptastatine
-
KXO2KT9N0G
URI
http://data.loterre.fr/ark:/67375/JVR-GCDJL5VH-L
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}